Regulatory Filings and Submissions

>

Latest News

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
EC Approves Imfinzi for Treatment of LS-SCLC

March 26th 2025

The commission’s approval makes durvalumab the first and only immunotherapy for LS-SCLC in the EU.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Australia Regulatory Authority Declines Approval of Eisai’s Lecanemab for Early Alzheimer’s Disease

March 11th 2025

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
EMA Recommends Imfinzi-Based Perioperative Regimen for Treating Resectable NSCLC

March 10th 2025

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
EMA Approves TAKHZYRO for Additional Subcutaneous Administration Option to Treat Hereditary Angioedema

March 7th 2025

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Regeneron Receives Positive Opinion from EMA for Relapsed and Refractory Multiple Myeloma

March 4th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.